Status:
RECRUITING
Risk Markers of Arterial Aging. The Paris Prospective Study III-2
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Arterial Stiffness
Eligibility:
All Genders
60-95 years
Brief Summary
The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subseq...
Detailed Description
Since May 2008, PPS3 is being following the CVD morbidity of 10157 healthy volunteers aged 50-75 years at baseline. In PPS3-2, we plan to re-invite survivors and volunteers of PPS3 to undergo a second...
Eligibility Criteria
Inclusion
- Being enrolled in PPS3 and having signed an informed consent for PPS3-2
Exclusion
- Institutionalized participants
- Participants under guardianship
- Participants under judicial safeguard measure
Key Trial Info
Start Date :
June 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2033
Estimated Enrollment :
7500 Patients enrolled
Trial Details
Trial ID
NCT06079424
Start Date
June 20 2025
End Date
December 1 2033
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'Investigation Précliniques
Paris, France, 75016